CYTOKINE-ASSOCIATED TISSUE-INJURY AND LETHALITY IN MICE - A COMPARATIVE-STUDY

被引:26
作者
SHALABY, MR
HALGUNSET, J
HAUGEN, OA
AARSET, H
AARDEN, L
WAAGE, A
MATSUSHIMA, K
KVITHYLL, H
BORASCHI, D
LAMVIK, J
ESPEVIK, T
机构
[1] UNIV TRONDHEIM,INST CANE RES,N-7006 TRONDHEIM,NORWAY
[2] UNIV AMSTERDAM,CENT LAB NETHERLANDS,AMSTERDAM,NETHERLANDS
[3] NCI,MOLEC IMMUNOREGULAT LAB,FREDERICK,MD 21701
[4] SCLAVO RES CTR,IMMUNOPHARMACOL LAB,SIENA,ITALY
来源
CLINICAL IMMUNOLOGY AND IMMUNOPATHOLOGY | 1991年 / 61卷 / 01期
关键词
D O I
10.1016/S0090-1229(06)80008-5
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
A comparative study was performed to examine the lethal effects of several cytokines injected into mice sensitized with actinomycin D (Act-D). Consistent with published data, human tumor necrosis factor-α (TNF-α) and interleukin-1β (IL-1β) (0.2-5 μg) caused the death of the animals within 8-12 hr after injection. Human interleukin-6 (IL-6) and interleukin-8 (IL-8) (0.6-6 μg) known to be induced by TNF-α did not show any lethal effects, indicating that TNF-α-associated lethality is not mediated by IL-6 or IL-8. Human tumor necrosis factor-β (TNF-β) (also called lymphotoxin), which shares structural and functional properties with TNF-α, was as potent as TNF-α in its lethal effects. Murine interferon-γ (IFN-γ) (0.04-5 μg) was also tested and showed no lethal effects in this model. In addition, a synthetic peptide corresponding to amino acid residues 163-171 of IL-1β, and which has been shown to lack the inflammatory effects of IL-1β, also caused no lethality among Act-D sensitized mice. The pretreatment of mice with IL-6, IL-8, or IFN-γ had no protective effects on TNF-α or IL-1β-induced lethality in contrast to the protection observed by a pretreatment with TNF-α/IL-1β themselves or with endotoxin. Histopathologic data showed that severe tissue injury in vital organs is associated with the rapid lethality among sensitized mice. © 1991 Academic Press, Inc.
引用
收藏
页码:69 / 82
页数:14
相关论文
共 35 条
[1]  
ANTONI G, 1986, J IMMUNOL, V137, P3201
[2]  
BADGER AM, 1989, CIRC SHOCK, V27, P51
[3]   PROTECTIVE EFFECT OF CHLORPROMAZINE AGAINST THE LETHALITY OF INTERLEUKIN-1 IN ADRENALECTOMIZED OR ACTINOMICIN-D-SENSITIZED MICE [J].
BERTINI, R ;
BIANCHI, M ;
MENGOZZI, M ;
GHEZZI, P .
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 1989, 165 (03) :942-946
[4]   INVIVO STIMULATION AND RESTORATION OF THE IMMUNE-RESPONSE BY THE NONINFLAMMATORY FRAGMENT 163-171 OF HUMAN INTERLEUKIN-1-BETA [J].
BORASCHI, D ;
NENCIONI, L ;
VILLA, L ;
CENSINI, S ;
BOSSU, P ;
GHIARA, P ;
PRESENTINI, R ;
PERIN, F ;
FRASCA, D ;
DORIA, G ;
FORNI, G ;
MUSSO, T ;
GIOVARELLI, M ;
GHEZZI, P ;
BERTINI, R ;
BESEDOVSKY, HO ;
DELREY, A ;
SIPE, JD ;
ANTONI, G ;
SILVESTRI, S ;
TAGLIABUE, A .
JOURNAL OF EXPERIMENTAL MEDICINE, 1988, 168 (02) :675-686
[5]  
BRAKENHOFF JPJ, 1990, J IMMUNOL, V145, P561
[6]   TUMOR NECROSIS FACTOR CAUSES AMPLIFICATION OF ARACHIDONIC-ACID METABOLISM IN RESPONSE TO INTERLEUKIN-1, BRADYKININ, AND OTHER AGONISTS [J].
BURCH, RM ;
TIFFANY, CW .
JOURNAL OF CELLULAR PHYSIOLOGY, 1989, 141 (01) :85-89
[7]   INTERLEUKIN-1 SUPPRESSES INFLAMMATION IN RABBIT COLITIS - MEDIATION BY ENDOGENOUS PROSTAGLANDINS [J].
COMINELLI, F ;
NAST, CC ;
LLERENA, R ;
DINARELLO, CA ;
ZIPSER, RD .
JOURNAL OF CLINICAL INVESTIGATION, 1990, 85 (02) :582-586
[8]   CLONING AND EXPRESSION OF MURINE IMMUNE INTERFERON CDNA [J].
GRAY, PW ;
GOEDDEL, DV .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA-BIOLOGICAL SCIENCES, 1983, 80 (19) :5842-5846
[9]   CLONING AND EXPRESSION OF CDNA FOR HUMAN LYMPHOTOXIN, A LYMPHOKINE WITH TUMOR NECROSIS ACTIVITY [J].
GRAY, PW ;
AGGARWAL, BB ;
BENTON, CV ;
BRINGMAN, TS ;
HENZEL, WJ ;
JARRETT, JA ;
LEUNG, DW ;
MOFFAT, B ;
NG, P ;
SVEDERSKY, LP ;
PALLADINO, MA ;
NEDWIN, GE .
NATURE, 1984, 312 (5996) :721-724
[10]   FUNCTIONAL DISCRIMINATION BETWEEN INTERLEUKIN-6 AND INTERLEUKIN-1 [J].
HELLE, M ;
BOEIJE, L ;
AARDEN, LA .
EUROPEAN JOURNAL OF IMMUNOLOGY, 1988, 18 (10) :1535-1540